Higher PAK1 expression was associated with shorter overall survival (OS) and BCAT1, though has no correlation with OS, its combination with PAK1 assisted in differentiating CLL patients with poor outcomes (Fig. 5G–I). This evidence concerns the gene PAK1 and B-cell chronic lymphocytic leukemia.